Lysophosphatidic Acid (LPA) Receptors: Signaling Properties and Disease Relevance

Overview

Journal Prostaglandins Other Lipid Mediat

Date 2010 Mar 25

PMID 20331961

Citations 161

Authors

Mu-En Lin

Deron R Herr

Jerold Chun

Affiliations

Soon will be listed here.

Abstract

Lysophosphatidic acid (LPA), a water-soluble phospholipid, has gained significant attention in recent years since the discovery that it acts as a potent signaling molecule with wide-ranging effects on many different target tissues. There are currently five identified G protein-coupled receptors for LPA and more are undergoing validation. The complexity of the expression pattern and signaling properties of LPA receptors results in multiple influences on developmental, physiological, and pathological processes. This review provides a summary of LPA receptor signaling and current views on the potential involvement of this pathway in human diseases that include cardiovascular, cancer, neuropathic pain, neuropsychiatric disorders, reproductive disorders, and fibrosis. The involvement of LPA signaling in these processes implicates multiple, potential drug targets including LPA receptor subtypes and LPA metabolizing enzymes. Modulation of LPA signaling may thus provide therapeutic inroads for the treatment of human disease.

Citing Articles

The effect of lysophosphatidic acid on myometrial contractility and the mRNA transcription of its receptors in the myometrium at different stages of endometrosis in mares.

Piotrowska-Tomala K, Szostek-Mioduchowska A, Jonczyk A, Drzewiecka E, Wrobel M, Hojo T BMC Vet Res. 2024; 20(1):571.

PMID: 39696406 PMC: 11658124. DOI: 10.1186/s12917-024-04384-2.

What Is on the Horizon for Treatments in Idiopathic Pulmonary Fibrosis?.

Moua T, Baqir M, Ryu J J Clin Med. 2024; 13(21).

PMID: 39518443 PMC: 11546700. DOI: 10.3390/jcm13216304.

Roles of lysophosphatidic acid (LPA) receptor-mediated signaling in cancer cell biology.

Takai M, Mori S, Honoki K, Tsujiuchi T J Bioenerg Biomembr. 2024; 56(4):475-482.

PMID: 38886303 DOI: 10.1007/s10863-024-10028-9.

First insight about the ability of specific glycerophospholipids to discriminate non-small cell lung cancer subtypes.

Sieminska J, Miniewska K, Mroz R, Sierko E, Naumnik W, Kisluk J Front Mol Biosci. 2024; 11:1379631.

PMID: 38725870 PMC: 11079276. DOI: 10.3389/fmolb.2024.1379631.

Effects of Regulating Hippo and Wnt on the Development and Fate Differentiation of Bovine Embryo.

Zhang P, Zhang H, Li C, Yang B, Feng X, Cao J Int J Mol Sci. 2024; 25(7).

PMID: 38612721 PMC: 11011455. DOI: 10.3390/ijms25073912.

References

Obo Y, Yamada T, Furukawa M, Hotta M, Honoki K, Fukushima N . Frequent mutations of lysophosphatidic acid receptor-1 gene in rat liver tumors. Mutat Res. 2008; 660(1-2):47-50. DOI: 10.1016/j.mrfmmm.2008.10.005. View

Matas-Rico E, Garcia-Diaz B, Llebrez-Zayas P, Lopez-Barroso D, Santin L, Pedraza C . Deletion of lysophosphatidic acid receptor LPA1 reduces neurogenesis in the mouse dentate gyrus. Mol Cell Neurosci. 2008; 39(3):342-55. PMC: 3667670. DOI: 10.1016/j.mcn.2008.07.014. View

Lee J, Park S, Lee E, Park C, Chung H, Rha S . Activation of hypoxia-inducible factor-1alpha is necessary for lysophosphatidic acid-induced vascular endothelial growth factor expression. Clin Cancer Res. 2006; 12(21):6351-8. DOI: 10.1158/1078-0432.CCR-06-1252. View

Amir R, Devor M . Functional cross-excitation between afferent A- and C-neurons in dorsal root ganglia. Neuroscience. 2000; 95(1):189-95. DOI: 10.1016/s0306-4522(99)00388-7. View

Dvorak H, Sioussat T, Brown L, Berse B, Nagy J, Sotrel A . Distribution of vascular permeability factor (vascular endothelial growth factor) in tumors: concentration in tumor blood vessels. J Exp Med. 1991; 174(5):1275-8. PMC: 2118980. DOI: 10.1084/jem.174.5.1275. View

Chen J, Chen Y, Zhu W, Han Y, Han B, Xu R . Specific LPA receptor subtype mediation of LPA-induced hypertrophy of cardiac myocytes and involvement of Akt and NFkappaB signal pathways. J Cell Biochem. 2007; 103(6):1718-31. DOI: 10.1002/jcb.21564. View

Kotarsky K, Boketoft A, Bristulf J, Nilsson N, Norberg A, Hansson S . Lysophosphatidic acid binds to and activates GPR92, a G protein-coupled receptor highly expressed in gastrointestinal lymphocytes. J Pharmacol Exp Ther. 2006; 318(2):619-28. DOI: 10.1124/jpet.105.098848. View

Aoki J, Inoue A, Okudaira S . Two pathways for lysophosphatidic acid production. Biochim Biophys Acta. 2008; 1781(9):513-8. DOI: 10.1016/j.bbalip.2008.06.005. View

Brauer A, Nitsch R . Plasticity-related genes (PRGs/LRPs): a brain-specific class of lysophospholipid-modifying proteins. Biochim Biophys Acta. 2008; 1781(9):595-600. DOI: 10.1016/j.bbalip.2008.04.004. View

10.

Estivill-Torrus G, Llebrez-Zayas P, Matas-Rico E, Santin L, Pedraza C, de Diego I . Absence of LPA1 signaling results in defective cortical development. Cereb Cortex. 2007; 18(4):938-50. DOI: 10.1093/cercor/bhm132. View

11.

Inoue M, Xie W, Matsushita Y, Chun J, Aoki J, Ueda H . Lysophosphatidylcholine induces neuropathic pain through an action of autotaxin to generate lysophosphatidic acid. Neuroscience. 2008; 152(2):296-8. DOI: 10.1016/j.neuroscience.2007.12.041. View

12.

Pustilnik T, Estrella V, Wiener J, Mao M, Eder A, Watt M . Lysophosphatidic acid induces urokinase secretion by ovarian cancer cells. Clin Cancer Res. 1999; 5(11):3704-10. View

13.

Kim K, Li B, Winer J, Armanini M, Gillett N, PHILLIPS H . Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature. 1993; 362(6423):841-4. DOI: 10.1038/362841a0. View

14.

Fukushima N, Morita Y . Actomyosin-dependent microtubule rearrangement in lysophosphatidic acid-induced neurite remodeling of young cortical neurons. Brain Res. 2006; 1094(1):65-75. DOI: 10.1016/j.brainres.2006.04.007. View

15.

Das A, HAJRA A . Quantification, characterization and fatty acid composition of lysophosphatidic acid in different rat tissues. Lipids. 1989; 24(4):329-33. DOI: 10.1007/BF02535172. View

16.

Bian D, Su S, Mahanivong C, Cheng R, Han Q, Pan Z . Lysophosphatidic Acid Stimulates Ovarian Cancer Cell Migration via a Ras-MEK Kinase 1 Pathway. Cancer Res. 2004; 64(12):4209-17. DOI: 10.1158/0008-5472.CAN-04-0060. View

17.

Yanagida K, Ishii S, Hamano F, Noguchi K, Shimizu T . LPA4/p2y9/GPR23 mediates rho-dependent morphological changes in a rat neuronal cell line. J Biol Chem. 2006; 282(8):5814-24. DOI: 10.1074/jbc.M610767200. View

18.

Quincozes-Santos A, Abib R, Leite M, Bobermin D, Bambini-Junior V, Goncalves C . Effect of the atypical neuroleptic risperidone on morphology and S100B secretion in C6 astroglial lineage cells. Mol Cell Biochem. 2008; 314(1-2):59-63. DOI: 10.1007/s11010-008-9765-x. View

19.

Contos J, Ishii I, Fukushima N, Kingsbury M, Ye X, Kawamura S . Characterization of lpa(2) (Edg4) and lpa(1)/lpa(2) (Edg2/Edg4) lysophosphatidic acid receptor knockout mice: signaling deficits without obvious phenotypic abnormality attributable to lpa(2). Mol Cell Biol. 2002; 22(19):6921-9. PMC: 134025. DOI: 10.1128/MCB.22.19.6921-6929.2002. View

20.

Hama K, Aoki J, Fukaya M, Kishi Y, Sakai T, Suzuki R . Lysophosphatidic acid and autotaxin stimulate cell motility of neoplastic and non-neoplastic cells through LPA1. J Biol Chem. 2004; 279(17):17634-9. DOI: 10.1074/jbc.M313927200. View